Home » Topics » Regulatory » EMA

EMA
RSS

EMA committee backs approval of Zykadia for first-line use in ALK+ NSCLC

May 22, 2017

EMA validates application seeking expanded approval of Sprycel

May 22, 2017

CHMP recommends approval of Insulin lispro Sanofi

May 22, 2017

EMA committee hands down positive opinion on Veltassa for treatment of hyperkalemia

May 19, 2017

CHMP adopts negative opinion for masitinib in indolent systemic mastocytosis

May 19, 2017

Apellis Pharmaceuticals granted E.U. orphan drug designation for APL-2 in PNH

May 10, 2017

EMA grants PRIME designation to AMT-060 in hemophilia B

April 26, 2017

EMA committee recommends approval of Skilarence for psoriasis

April 25, 2017

EMA committee adopts positive opinion on Opdivo in locally advanced or metastatic urothelial cancer

April 24, 2017

EMA committee recommends E.U. approval of Kevzara

April 24, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...